PsyBio Therapeutics Corp V.PSYB

Primary Symbol: V.PSYB.H Alternate Symbol(s): PSYBF

Healthcare Biotechnology

PsyBio Therapeutics Corp. is a Canada-based biotechnology company. The Company is focused on discovering, designing and developing psycho-focused therapeutics to improve mental and neurological conditions. It is focused on understanding the value of tryptamines and other related psycho-targeted molecules as therapeutic candidates to improve mental and neurological health. The Company is engaged in research and development for occurring psychoactive tryptamines, which is originally discovered in different varieties of hallucinogenic mushrooms, other tryptamines and phenethylamines, and combinations thereof. The Company utilizes a bio-medicinal chemistry approach to therapeutic development, in which psychoactive compounds can be utilized as a template upon, which to develop precursors and analogs, both naturally and non-naturally occurring.

TSXV:PSYB.H - Post by User

PsyBio Therapeutics Corp > $ORIG to ipo super soon!

<< Previous

Bullboard Posts

Next >>

Comment by partystockeron Jan 05, 2022 4:08pm

174 Views

Post# 34286775

RE:$ORIG to ipo super soon!

With the psychedelics industry currently resting at all time lows, now probably isn't the best time for Origin to hit the market. But the positive side of this is that Origin has a great opportunity to time going public with a swing in the market, hopefully leading to a strong IPO.

We’ll hopefully see some updated guidance from Origin’s leadership this quarter as to what the company’s plans are for going public.

Origin has a pretty enticing investor package that is available here. Definitely worth taking a look at IMO.

https://originpsychedelics.com/investors/?gclid=Cj0KCQiAq7COBhC2ARIsANsPATEmrShLff1iHcZFxWVMiPr7O3nO1k9HyWy8FMjBW-_7q9jxabfa35oaAjzIEALw_wcB

<< Previous

Bullboard Posts

Next >>

Bombardier allows its cash tender offer to expire